Melanie De Almeida
French Immunotherapy Biotech Teams up With Renowned Cancer Center
French Hepatitis Cure is on Track with Positive Phase I Results
Update: Belgian Stem Cell Therapy Closer to Market with Phase III Launch
German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases
Missed Labiotech Refresh? Have a Look at Our Recap!
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
Norwegian Biotech Hits €21M in Private Placement for its Immunotherapies
German Biotech Unveils Positive Phase II Results for Alzheimer’s
This UK Biotech Wants to Protect People from Hearing Loss
Austrian Biotech Kicks-off NIH-sponsored Trial of its Chikungunya Vaccine
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
This French Biotech Wants to Reinvent DC-based Immunotherapies
Labiotech UG, All Rights Reserved -
Send this to friend